|
|
|
Insider
Information: |
Myles Edward H |
Relationship: |
|
City: |
Swansea |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
311,635 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$4,422,043 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
311,635 |
|
|
Total
Value |
$4,422,043 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-24.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pressure Biosciences Inc |
PBIO |
VP of Finance & CFO |
2006-09-07 |
2,000 |
2006-08-28 |
0 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
COO & CFO |
2020-03-10 |
98,659 |
2016-04-11 |
0 |
Premium* |
|
Scholar Rock Holding Corp |
SRRK |
|
2024-02-16 |
210,976 |
2021-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2024-02-16 |
4 |
S |
$15.74 |
$74,686 |
D/D |
(4,744) |
210,976 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
53,570 |
215,720 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2024-01-16 |
4 |
S |
$15.93 |
$105,670 |
D/D |
(6,634) |
162,150 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-12-29 |
4 |
AS |
$18.82 |
$234,633 |
D/D |
(12,459) |
168,784 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-12-29 |
4 |
OE |
$4.86 |
$60,551 |
D/D |
12,459 |
181,243 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-12-07 |
4 |
AS |
$17.53 |
$436,820 |
D/D |
(24,914) |
168,784 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-12-07 |
4 |
OE |
$4.86 |
$121,082 |
D/D |
24,914 |
193,698 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-06-21 |
4 |
D |
$8.75 |
$62,456 |
D/D |
(7,138) |
203,791 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
63,750 |
210,929 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2023-01-17 |
4 |
D |
$11.29 |
$79,503 |
D/D |
(7,043) |
147,179 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2022-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
74,750 |
154,222 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
COO & CFO |
|
2022-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
57,500 |
79,472 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2022-01-18 |
4 |
D |
$19.46 |
$42,390 |
D/D |
(2,178) |
21,972 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-15 |
4 |
AS |
$35.05 |
$171,006 |
D/D |
(4,879) |
24,150 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,879 |
29,029 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-12 |
4 |
AS |
$35.12 |
$1,750,437 |
D/D |
(49,848) |
24,150 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,848 |
73,998 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-11 |
4 |
AS |
$35.20 |
$829,857 |
D/D |
(23,574) |
24,150 |
0 |
% |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-11-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,574 |
47,724 |
0 |
- |
|
SRRK |
Scholar Rock Holding Corp |
Chief Financial Officer |
|
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,150 |
24,150 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
COO & CFO |
|
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
98,659 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
COO & CFO |
|
2020-03-02 |
4 |
D |
$7.75 |
$7,913 |
D/D |
(1,021) |
68,659 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
COO & CFO |
|
2020-02-25 |
4 |
D |
$8.84 |
$12,252 |
D/D |
(1,386) |
77,180 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
COO & CFO |
|
2020-02-23 |
4 |
D |
$9.50 |
$8,237 |
D/D |
(867) |
78,566 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Chief Financial Officer |
|
2019-04-11 |
4 |
D |
$12.47 |
$24,491 |
D/D |
(1,964) |
79,433 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|